This document provides an evaluation approach for classifying and diagnosing different types of anemia based on patient history and examination findings. It outlines a step-wise approach beginning with determining if the anemia is associated with other hematological abnormalities by examining the bone marrow. It then evaluates the anemia based on red blood cell indices to determine if it is macrocytic, microcytic, or normocytic. For each type of anemia, it provides guidance on further tests and evaluations to identify potential underlying causes. The overall approach is to methodically classify the anemia and then investigate potential etiologies through additional lab tests, bone marrow examination, and considering common associated conditions.
The document discusses anemia, defining it as a hemoglobin level below 130g/L for men and 120g/L for women. Anemia is initially classified based on erythropoiesis, which involves EPO production, iron availability, bone marrow proliferative capacity, and red blood cell maturation. Causes of anemia include blood loss, hemolysis, bone marrow diseases, and deficiencies. Evaluation involves history, exam, blood tests of cell counts and indices, smear examination, iron studies, and bone marrow analysis. Treatment depends on the underlying cause.
Pancytopenia is a condition defined by low levels of red blood cells, white blood cells, and platelets. It can be caused by bone marrow failure, bone marrow infiltration, ineffective hematopoiesis, or peripheral destruction/pooling of blood cells. Evaluating the history, examination, blood counts, blood film, bone marrow aspiration/biopsy, and other tests can help determine the underlying cause, such as aplastic anemia, leukemia, lymphoma, or myelodysplastic syndrome. The bone marrow may appear hypocellular, normocellular, or hypercellular, providing clues to diagnoses like aplastic anemia or hematologic malignancies.
IDA is the most common form of anemia worldwide, affecting approximately 50% of anemia cases. It results from prolonged negative iron balance in the body due to factors like inadequate iron intake, decreased absorption, increased demand, or blood loss. Diagnosis involves a complete history, physical exam, and lab tests showing low indicators of iron stores like serum ferritin and iron, along with an elevated TIBC. Treatment aims to replenish iron stores and typically consists of oral iron supplementation of 200mg elemental iron per day for 3-6 months.
This document discusses hemolytic anemia and focuses on sickle cell disease. It defines hemolytic anemia as increased destruction of red blood cells outside the bone marrow. Key diagnostic findings include increased reticulocyte count, hyperbilirubinemia, decreased haptoglobin, and increased lactate dehydrogenase. Hemolytic anemias are classified as hereditary defects within red blood cells or acquired external causes. Sickle cell disease results from a hereditary hemoglobinopathy and causes chronic hemolytic anemia. Complications include infections, acute chest syndrome, stroke, leg ulcers, splenic sequestration, and retinopathy. Diagnosis is made by finding sickle cells on peripheral smear and abnormal hem
Dr Sarath Menon presents an approach to diagnosing and classifying hemolytic anemia. Hemolytic anemia results from increased red blood cell destruction and bone marrow compensation. It can be congenital/hereditary or acquired. Classification includes intracorpuscular defects like hemoglobinopathies and enzymopathies, and extracorpuscular factors like mechanical destruction, toxic agents, infections, and autoimmune causes. Diagnosis involves confirming hemolysis and determining the etiology through history, physical exam, peripheral smear, and ancillary lab tests. Common etiologies discussed in detail include sickle cell disease, thalassemia, G6PD deficiency, membrane defects like hereditary spherocytosis, and autoimmune
basics about chronic liver disease for a pediatrician. fast and easy guide to common causes of chronic liver diseases in children
Please leave a comment if you like it..
Pancytopenia is a reduction in red blood cells, white blood cells, and platelets. The document outlines an approach to evaluating a case of pancytopenia, including considering decreased bone marrow production, increased cell destruction, a thorough history and physical exam, and diagnostic tests like complete blood count, peripheral smear, and bone marrow aspiration and biopsy to determine the underlying cause. The causes of pancytopenia are grouped based on mechanism and include conditions like aplastic anemia, megaloblastic anemia, myelodysplastic syndrome, liver disease, and others.
This case presentation describes a 24-year-old female patient who was admitted to the hospital with symptoms of weakness, shortness of breath, fever, and recurrent nosebleeds. Laboratory tests showed very low blood cell counts. A bone marrow examination found a markedly hypocellular marrow with few hematopoietic cells. The patient was diagnosed with aplastic anemia based on pancytopenia, low bone marrow cellularity, and no evidence of damage to stem cells or dysplasia. Aplastic anemia is a rare disease caused by damage to or decrease in bone marrow stem cells resulting in bone marrow failure and replacement with fat.
The document discusses anemia, defining it as a hemoglobin level below 130g/L for men and 120g/L for women. Anemia is initially classified based on erythropoiesis, which involves EPO production, iron availability, bone marrow proliferative capacity, and red blood cell maturation. Causes of anemia include blood loss, hemolysis, bone marrow diseases, and deficiencies. Evaluation involves history, exam, blood tests of cell counts and indices, smear examination, iron studies, and bone marrow analysis. Treatment depends on the underlying cause.
Pancytopenia is a condition defined by low levels of red blood cells, white blood cells, and platelets. It can be caused by bone marrow failure, bone marrow infiltration, ineffective hematopoiesis, or peripheral destruction/pooling of blood cells. Evaluating the history, examination, blood counts, blood film, bone marrow aspiration/biopsy, and other tests can help determine the underlying cause, such as aplastic anemia, leukemia, lymphoma, or myelodysplastic syndrome. The bone marrow may appear hypocellular, normocellular, or hypercellular, providing clues to diagnoses like aplastic anemia or hematologic malignancies.
IDA is the most common form of anemia worldwide, affecting approximately 50% of anemia cases. It results from prolonged negative iron balance in the body due to factors like inadequate iron intake, decreased absorption, increased demand, or blood loss. Diagnosis involves a complete history, physical exam, and lab tests showing low indicators of iron stores like serum ferritin and iron, along with an elevated TIBC. Treatment aims to replenish iron stores and typically consists of oral iron supplementation of 200mg elemental iron per day for 3-6 months.
This document discusses hemolytic anemia and focuses on sickle cell disease. It defines hemolytic anemia as increased destruction of red blood cells outside the bone marrow. Key diagnostic findings include increased reticulocyte count, hyperbilirubinemia, decreased haptoglobin, and increased lactate dehydrogenase. Hemolytic anemias are classified as hereditary defects within red blood cells or acquired external causes. Sickle cell disease results from a hereditary hemoglobinopathy and causes chronic hemolytic anemia. Complications include infections, acute chest syndrome, stroke, leg ulcers, splenic sequestration, and retinopathy. Diagnosis is made by finding sickle cells on peripheral smear and abnormal hem
Dr Sarath Menon presents an approach to diagnosing and classifying hemolytic anemia. Hemolytic anemia results from increased red blood cell destruction and bone marrow compensation. It can be congenital/hereditary or acquired. Classification includes intracorpuscular defects like hemoglobinopathies and enzymopathies, and extracorpuscular factors like mechanical destruction, toxic agents, infections, and autoimmune causes. Diagnosis involves confirming hemolysis and determining the etiology through history, physical exam, peripheral smear, and ancillary lab tests. Common etiologies discussed in detail include sickle cell disease, thalassemia, G6PD deficiency, membrane defects like hereditary spherocytosis, and autoimmune
basics about chronic liver disease for a pediatrician. fast and easy guide to common causes of chronic liver diseases in children
Please leave a comment if you like it..
Pancytopenia is a reduction in red blood cells, white blood cells, and platelets. The document outlines an approach to evaluating a case of pancytopenia, including considering decreased bone marrow production, increased cell destruction, a thorough history and physical exam, and diagnostic tests like complete blood count, peripheral smear, and bone marrow aspiration and biopsy to determine the underlying cause. The causes of pancytopenia are grouped based on mechanism and include conditions like aplastic anemia, megaloblastic anemia, myelodysplastic syndrome, liver disease, and others.
This case presentation describes a 24-year-old female patient who was admitted to the hospital with symptoms of weakness, shortness of breath, fever, and recurrent nosebleeds. Laboratory tests showed very low blood cell counts. A bone marrow examination found a markedly hypocellular marrow with few hematopoietic cells. The patient was diagnosed with aplastic anemia based on pancytopenia, low bone marrow cellularity, and no evidence of damage to stem cells or dysplasia. Aplastic anemia is a rare disease caused by damage to or decrease in bone marrow stem cells resulting in bone marrow failure and replacement with fat.
This document provides an overview of pancytopenia, including definitions, common causes, clinical evaluation, and diagnostic approach. Pancytopenia is defined as a reduction in all three blood cell lines. The evaluation involves obtaining a complete blood count with peripheral smear, bone marrow aspiration and biopsy, and specific tests depending on findings. The bone marrow examination can help differentiate causes based on cellularity and features seen in erythropoiesis, myelopoiesis, megakaryopoiesis and other cell types. Common causes include bone marrow failure, infiltrative disorders, infections, immune disorders and nutritional deficiencies. A thorough history, examination and systematic evaluation of the bone marrow are required to identify the underlying cause of pancy
This document provides information on interpreting a complete blood count (CBC). It defines various CBC parameters such as anisopokilocytosis, cytometry, and Coulter principle. The importance of the CBC is discussed as it can provide information about the blood, bone marrow, and health of other organs. The CBC evaluates components of the blood including red blood cell count, hemoglobin, hematocrit, and red cell indices. Abnormalities in these values can indicate conditions like anemia, bone marrow aplasia, and malignancies. Peripheral blood smear examination is also important for identifying red blood cell morphologies.
1. Aplastic anemia is a condition characterized by pancytopenia (low red blood cells, white blood cells, and platelets) due to bone marrow failure.
2. It can be caused by exposure to toxins, radiation, viruses, or immune system attacks on the bone marrow. The bone marrow is hypocellular with fatty replacement of hematopoietic tissue.
3. Symptoms include anemia, increased risk of infection, bruising/bleeding due to low blood cell counts. Diagnosis involves blood tests showing pancytopenia and a bone marrow biopsy revealing a hypocellular marrow. Treatment options include supportive care, immunosuppressants, bone marrow transplant, or androgens
This document discusses sideroblastic anemia, which is caused by an abnormal accumulation of iron in the mitochondria of red blood cell precursors called ring sideroblasts. There are several types of sideroblastic anemia, including hereditary forms caused by genetic mutations and acquired forms caused by drugs, toxins, or diseases. The condition is characterized by ring sideroblasts seen on bone marrow biopsy along with ineffective red blood cell production and iron overload. Treatment depends on the underlying cause but may include blood transfusions, vitamin supplements, iron chelation therapy, or bone marrow transplant in severe cases.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematopoietic stem cell disorder characterized by hemolytic anemia. It arises due to a somatic mutation in the PIGA gene, causing deficiency of glycosylphosphatidylinositol-anchored proteins (GPI-APs) like CD55 and CD59 on the surface of blood cells. This renders the cells highly sensitive to complement-mediated lysis. Diagnosis involves flow cytometry to detect GPI-AP deficiency and tests like Ham and sucrose hemolysis to demonstrate complement sensitivity of the red blood cells. PNH is associated with hemoglobinuria, thrombosis, and bone marrow failure. It requires differentiation
The document discusses the Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone (SIADH). It defines SIADH as excess secretion of anti-diuretic hormone (ADH) leading to hyponatremia. It describes the prevalence of hyponatremia, the causes and classification of SIADH into four types (A, B, C, D) based on patterns of ADH secretion. The clinical features of SIADH range from nausea to neurological symptoms depending on the severity and rate of change in sodium levels.
Polycythemia is a condition characterized by an abnormal increase in the red blood cell count. There are two types: relative polycythemia, caused by a decrease in plasma volume leading to a higher concentration of red blood cells; and absolute polycythemia, caused by overproduction of red blood cells in the bone marrow. Polycythemia vera is a specific myeloproliferative disorder and type of absolute polycythemia caused by a mutation in the JAK2 gene, leading to uncontrolled red blood cell production. Symptoms include headaches, dizziness, and blood flow issues from hyperviscosity. Treatment involves phlebotomy to reduce red blood cell counts and medications to control bone marrow
Multiple myeloma is a cancer of plasma cells that results in overproduction of abnormal antibodies in the bone marrow. It commonly causes bone pain, fractures, anemia, and kidney problems. Risk factors include age over 60 and exposure to chemicals like pesticides, radiation, or certain industrial chemicals. Treatment may include chemotherapy, steroids, stem cell transplantation, radiation, surgery, and newer drugs like thalidomide, lenalidomide, and bortezomib to improve outcomes. Despite recent advances, multiple myeloma remains incurable and patients often relapse, highlighting the need for additional therapeutic options.
Hemolytic anemias are caused by increased red blood cell destruction. They are characterized by normochromic, normocytic anemia with reticulocytosis, increased indirect bilirubin and LDH, and absent haptoglobin. Causes include membrane defects, metabolic abnormalities, hemoglobinopathies, and immune or non-immune mechanisms. Specific conditions discussed include hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, drug-induced hemolysis, alloimmune hemolytic anemia, and warm or cold autoimmune hemolytic anemia. Management depends on the underlying cause and may involve transfusions, medications, or splenectomy.
This document discusses the approach to evaluating a patient presenting with pallor. It begins by outlining the learning objectives which are to understand the importance of history and exam in workup of pallor, learn about causes and classification of anemia, how to interpret lab tests, and management of anemia. It then provides details on evaluating pallor, the definition of anemia, essential initial lab tests, and an approach to diagnostic workup of anemia based on mean corpuscular volume. Case examples are presented and discussed to demonstrate examples of iron deficiency anemia, vitamin B12/folate deficiency anemia, and sickle cell anemia. Management of iron deficiency anemia is also reviewed.
This document provides information on the definition, presentation, evaluation, investigation and treatment of anemia. It defines anemia as a hemoglobin level below certain thresholds based on sex. Anemia is often identified through screening tests but can sometimes present with symptoms of advanced anemia. Evaluation involves taking a medical history and performing a physical exam and blood tests. Based on test results, anemias are classified and specific treatment is given depending on the underlying cause, such as iron supplementation for iron deficiency anemia or blood transfusions for acute blood loss.
Felty's syndrome is a rare condition characterized by rheumatoid arthritis, neutropenia, and splenomegaly. It affects around 1-3% of rheumatoid arthritis patients, predominantly women aged 50-70 years. The cause involves autoantibodies that cause neutrophil destruction and inhibit granulopoiesis. Treatment focuses on controlling the underlying rheumatoid arthritis with medications like methotrexate as well as G-CSF or splenectomy to address the neutropenia and splenomegaly. Complications can include life-threatening infections.
Basic approach to a case of anemia. Investigations to do and to arrive at the diagnosis. (Management not discussed). Peripheral smear findings with pictures are included.
This document provides an overview of hemolytic anemia in children. It defines hemolytic anemia as anemia resulting from increased red blood cell destruction. The document describes the different types of hemolytic anemia including hereditary, immune, and non-immune causes. It outlines the pathophysiology, clinical features, diagnostic approach and management of common forms of hemolytic anemia in children such as hereditary spherocytosis, thalassemia, sickle cell anemia, and G6PD deficiency. Investigations for diagnosis include blood counts, peripheral smear, reticulocyte count, hemoglobin electrophoresis and enzyme or genetic testing depending on etiology.
Hemolytic anaemia can be classified as either intracorpuscular or extracorpuscular. Intracorpuscular hemolytic anemia is caused by abnormalities of red blood cell membranes, hemoglobin defects, or enzyme defects. Extracorpuscular hemolytic anemia can be immune-mediated or non-immune. Some specific causes of hemolytic anemia discussed in the document include hereditary spherocytosis, thalassemia, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, and autoimmune hemolytic anemia. The document provides details on epidemiology, etiology, pathogenesis, clinical features, diagnosis, and treatment of these conditions.
This document provides information on the diagnosis of anemia. It defines anemia and outlines the grading and classification systems. It discusses the prevalence of anemia globally and in India. The clinical presentation and diagnostic workup are described. Guidelines are provided on evaluating different types of anemia based on red blood cell indices, including iron deficiency anemia, thalassemia, megaloblastic anemia, aplastic anemia, anemia of chronic disease, and hemolytic anemias. Diagnostic testing for specific conditions like sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency is also reviewed.
This document provides information on autoimmune hepatitis, including:
- It is a chronic hepatitis of unknown etiology that can progress to cirrhosis. It is characterized by the presence of autoimmune antibodies and evidence of hepatitis.
- The two main types are type 1, associated with ANA/SMA positivity, and type 2, associated with LKM1 positivity.
- Treatment involves immunosuppressive drugs like prednisone, either alone or in combination with azathioprine. The goal is to induce and maintain remission.
- Remission is defined as resolution of symptoms and normalization of liver tests and histology. Treatment is then tapered slowly to maintain remission.
The document discusses the erythrocyte sedimentation rate (ESR) test, which indirectly measures inflammation in the body. The ESR reflects how quickly red blood cells settle in a tube, which is increased by factors related to inflammation like fibrinogen and acute-phase proteins. It is a non-specific screening test used to monitor inflammatory diseases and assess treatment effectiveness. The document also covers hemoglobin, the iron-containing protein in red blood cells that carries oxygen throughout the body. Hemoglobin levels can indicate conditions like anemia and diabetes. Additionally, it discusses the bone marrow, white blood cells, and factors that affect blood cell counts.
This document provides an overview of pancytopenia, including definitions, common causes, clinical evaluation, and diagnostic approach. Pancytopenia is defined as a reduction in all three blood cell lines. The evaluation involves obtaining a complete blood count with peripheral smear, bone marrow aspiration and biopsy, and specific tests depending on findings. The bone marrow examination can help differentiate causes based on cellularity and features seen in erythropoiesis, myelopoiesis, megakaryopoiesis and other cell types. Common causes include bone marrow failure, infiltrative disorders, infections, immune disorders and nutritional deficiencies. A thorough history, examination and systematic evaluation of the bone marrow are required to identify the underlying cause of pancy
This document provides information on interpreting a complete blood count (CBC). It defines various CBC parameters such as anisopokilocytosis, cytometry, and Coulter principle. The importance of the CBC is discussed as it can provide information about the blood, bone marrow, and health of other organs. The CBC evaluates components of the blood including red blood cell count, hemoglobin, hematocrit, and red cell indices. Abnormalities in these values can indicate conditions like anemia, bone marrow aplasia, and malignancies. Peripheral blood smear examination is also important for identifying red blood cell morphologies.
1. Aplastic anemia is a condition characterized by pancytopenia (low red blood cells, white blood cells, and platelets) due to bone marrow failure.
2. It can be caused by exposure to toxins, radiation, viruses, or immune system attacks on the bone marrow. The bone marrow is hypocellular with fatty replacement of hematopoietic tissue.
3. Symptoms include anemia, increased risk of infection, bruising/bleeding due to low blood cell counts. Diagnosis involves blood tests showing pancytopenia and a bone marrow biopsy revealing a hypocellular marrow. Treatment options include supportive care, immunosuppressants, bone marrow transplant, or androgens
This document discusses sideroblastic anemia, which is caused by an abnormal accumulation of iron in the mitochondria of red blood cell precursors called ring sideroblasts. There are several types of sideroblastic anemia, including hereditary forms caused by genetic mutations and acquired forms caused by drugs, toxins, or diseases. The condition is characterized by ring sideroblasts seen on bone marrow biopsy along with ineffective red blood cell production and iron overload. Treatment depends on the underlying cause but may include blood transfusions, vitamin supplements, iron chelation therapy, or bone marrow transplant in severe cases.
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hematopoietic stem cell disorder characterized by hemolytic anemia. It arises due to a somatic mutation in the PIGA gene, causing deficiency of glycosylphosphatidylinositol-anchored proteins (GPI-APs) like CD55 and CD59 on the surface of blood cells. This renders the cells highly sensitive to complement-mediated lysis. Diagnosis involves flow cytometry to detect GPI-AP deficiency and tests like Ham and sucrose hemolysis to demonstrate complement sensitivity of the red blood cells. PNH is associated with hemoglobinuria, thrombosis, and bone marrow failure. It requires differentiation
The document discusses the Syndrome of Inappropriate Secretion of Anti-Diuretic Hormone (SIADH). It defines SIADH as excess secretion of anti-diuretic hormone (ADH) leading to hyponatremia. It describes the prevalence of hyponatremia, the causes and classification of SIADH into four types (A, B, C, D) based on patterns of ADH secretion. The clinical features of SIADH range from nausea to neurological symptoms depending on the severity and rate of change in sodium levels.
Polycythemia is a condition characterized by an abnormal increase in the red blood cell count. There are two types: relative polycythemia, caused by a decrease in plasma volume leading to a higher concentration of red blood cells; and absolute polycythemia, caused by overproduction of red blood cells in the bone marrow. Polycythemia vera is a specific myeloproliferative disorder and type of absolute polycythemia caused by a mutation in the JAK2 gene, leading to uncontrolled red blood cell production. Symptoms include headaches, dizziness, and blood flow issues from hyperviscosity. Treatment involves phlebotomy to reduce red blood cell counts and medications to control bone marrow
Multiple myeloma is a cancer of plasma cells that results in overproduction of abnormal antibodies in the bone marrow. It commonly causes bone pain, fractures, anemia, and kidney problems. Risk factors include age over 60 and exposure to chemicals like pesticides, radiation, or certain industrial chemicals. Treatment may include chemotherapy, steroids, stem cell transplantation, radiation, surgery, and newer drugs like thalidomide, lenalidomide, and bortezomib to improve outcomes. Despite recent advances, multiple myeloma remains incurable and patients often relapse, highlighting the need for additional therapeutic options.
Hemolytic anemias are caused by increased red blood cell destruction. They are characterized by normochromic, normocytic anemia with reticulocytosis, increased indirect bilirubin and LDH, and absent haptoglobin. Causes include membrane defects, metabolic abnormalities, hemoglobinopathies, and immune or non-immune mechanisms. Specific conditions discussed include hereditary spherocytosis, glucose-6-phosphate dehydrogenase deficiency, paroxysmal nocturnal hemoglobinuria, drug-induced hemolysis, alloimmune hemolytic anemia, and warm or cold autoimmune hemolytic anemia. Management depends on the underlying cause and may involve transfusions, medications, or splenectomy.
This document discusses the approach to evaluating a patient presenting with pallor. It begins by outlining the learning objectives which are to understand the importance of history and exam in workup of pallor, learn about causes and classification of anemia, how to interpret lab tests, and management of anemia. It then provides details on evaluating pallor, the definition of anemia, essential initial lab tests, and an approach to diagnostic workup of anemia based on mean corpuscular volume. Case examples are presented and discussed to demonstrate examples of iron deficiency anemia, vitamin B12/folate deficiency anemia, and sickle cell anemia. Management of iron deficiency anemia is also reviewed.
This document provides information on the definition, presentation, evaluation, investigation and treatment of anemia. It defines anemia as a hemoglobin level below certain thresholds based on sex. Anemia is often identified through screening tests but can sometimes present with symptoms of advanced anemia. Evaluation involves taking a medical history and performing a physical exam and blood tests. Based on test results, anemias are classified and specific treatment is given depending on the underlying cause, such as iron supplementation for iron deficiency anemia or blood transfusions for acute blood loss.
Felty's syndrome is a rare condition characterized by rheumatoid arthritis, neutropenia, and splenomegaly. It affects around 1-3% of rheumatoid arthritis patients, predominantly women aged 50-70 years. The cause involves autoantibodies that cause neutrophil destruction and inhibit granulopoiesis. Treatment focuses on controlling the underlying rheumatoid arthritis with medications like methotrexate as well as G-CSF or splenectomy to address the neutropenia and splenomegaly. Complications can include life-threatening infections.
Basic approach to a case of anemia. Investigations to do and to arrive at the diagnosis. (Management not discussed). Peripheral smear findings with pictures are included.
This document provides an overview of hemolytic anemia in children. It defines hemolytic anemia as anemia resulting from increased red blood cell destruction. The document describes the different types of hemolytic anemia including hereditary, immune, and non-immune causes. It outlines the pathophysiology, clinical features, diagnostic approach and management of common forms of hemolytic anemia in children such as hereditary spherocytosis, thalassemia, sickle cell anemia, and G6PD deficiency. Investigations for diagnosis include blood counts, peripheral smear, reticulocyte count, hemoglobin electrophoresis and enzyme or genetic testing depending on etiology.
Hemolytic anaemia can be classified as either intracorpuscular or extracorpuscular. Intracorpuscular hemolytic anemia is caused by abnormalities of red blood cell membranes, hemoglobin defects, or enzyme defects. Extracorpuscular hemolytic anemia can be immune-mediated or non-immune. Some specific causes of hemolytic anemia discussed in the document include hereditary spherocytosis, thalassemia, sickle cell anemia, glucose-6-phosphate dehydrogenase deficiency, and autoimmune hemolytic anemia. The document provides details on epidemiology, etiology, pathogenesis, clinical features, diagnosis, and treatment of these conditions.
This document provides information on the diagnosis of anemia. It defines anemia and outlines the grading and classification systems. It discusses the prevalence of anemia globally and in India. The clinical presentation and diagnostic workup are described. Guidelines are provided on evaluating different types of anemia based on red blood cell indices, including iron deficiency anemia, thalassemia, megaloblastic anemia, aplastic anemia, anemia of chronic disease, and hemolytic anemias. Diagnostic testing for specific conditions like sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency is also reviewed.
This document provides information on autoimmune hepatitis, including:
- It is a chronic hepatitis of unknown etiology that can progress to cirrhosis. It is characterized by the presence of autoimmune antibodies and evidence of hepatitis.
- The two main types are type 1, associated with ANA/SMA positivity, and type 2, associated with LKM1 positivity.
- Treatment involves immunosuppressive drugs like prednisone, either alone or in combination with azathioprine. The goal is to induce and maintain remission.
- Remission is defined as resolution of symptoms and normalization of liver tests and histology. Treatment is then tapered slowly to maintain remission.
The document discusses the erythrocyte sedimentation rate (ESR) test, which indirectly measures inflammation in the body. The ESR reflects how quickly red blood cells settle in a tube, which is increased by factors related to inflammation like fibrinogen and acute-phase proteins. It is a non-specific screening test used to monitor inflammatory diseases and assess treatment effectiveness. The document also covers hemoglobin, the iron-containing protein in red blood cells that carries oxygen throughout the body. Hemoglobin levels can indicate conditions like anemia and diabetes. Additionally, it discusses the bone marrow, white blood cells, and factors that affect blood cell counts.
The Erythrocyte Sedimentation Rate (ESR or "sed rate") test measures the rate at which red blood cells settle in a tube of blood over one hour. A faster settlement rate indicates inflammation in the body from conditions like arthritis, infections, or cancers. The ESR is affected by many factors including plasma proteins, red blood cell properties, temperature, and technical variables. While not diagnostic on its own, an increased ESR can suggest an ongoing disease process and guide further investigation and monitoring of inflammatory conditions.
Red blood cells (RBCs), also called erythrocytes, are the most common type of blood cell and the vertebrate organism's principal means of delivering oxygen (O2) to the body tissues—via blood flow through the circulatory system.
The document discusses various components of a basic blood test. It provides details on the normal composition and functions of blood, as well as procedures for blood specimen collection. It also explains the clinical implications and reference ranges for various components analyzed in a complete blood count test, including red blood cells, white blood cells, platelets, hematocrit, hemoglobin, and sedimentation rate.
The document discusses the erythrocyte sedimentation rate (ESR) test, which is a common screening test for inflammation. ESR measures how fast red blood cells settle in a tube, which increases when inflammatory proteins like fibrinogen cause the cells to stick together and form stacks. While non-specific, ESR is inexpensive and widely available, making it a useful initial screening test or tool to monitor treatment response. The document provides details on how to perform the test, normal ranges, factors that impact results, and examples of conditions where ESR may be elevated.
Anaemia is a condition characterized by a reduced concentration of haemoglobin in the blood. Some key points:
- There are many potential causes of anaemia including blood loss, iron deficiency, vitamin deficiencies, kidney or liver disease, bone marrow disorders, and genetic conditions.
- Diagnosis involves a complete blood count and other tests to determine the size, shape, and number of red blood cells and check for deficiencies of iron, vitamin B12, and folic acid.
- Treatment depends on the underlying cause but may include iron supplements, vitamin supplements, medications, blood transfusions, or treating any underlying diseases causing the anaemia.
Este documento trata sobre las anemias. Define la anemia como un desbalance entre el aporte y la demanda de oxígeno manifestado por una disminución de la hemoglobina. Explica que las anemias se pueden clasificar según su evolución, morfología, fisiopatología y amplitud de distribución de los eritrocitos. Describe las causas, manifestaciones clínicas, diagnóstico y tratamiento de las anemias más comunes como la ferropénica, megaloblástica por déficit de vitamina B12 y
Anemia is a major health problem in India, especially among women. Some key points about anemia from the document include:
- Anemia is defined as a decrease in red blood cells or hemoglobin in the blood. It can be caused by blood loss, impaired red blood cell production, or increased red blood cell destruction.
- The main types of anemia are microcytic (small RBCs), macrocytic (large RBCs), and normocytic (normal sized RBCs). Common causes include iron deficiency, vitamin B12/folate deficiency, and aplastic anemia.
- Symptoms vary depending on the type and severity of anemia but can include pal
This document discusses the erythrocyte sedimentation rate (ESR) test, including the objectives, principle, mechanism, factors affecting ESR, clinical significance, and methods of estimating ESR. ESR is a non-specific test that measures how far red blood cells fall in one hour, indicating inflammation. The rate depends on factors that promote or resist sedimentation and is affected by physiological conditions and test variables. An increased ESR may indicate infection, inflammation or disease while a decreased ESR can occur in certain blood disorders. Common estimation methods include Wintrobe's, Westergren's and automated techniques.
Electron spin resonance (ESR) spectroscopy is a technique used to study compounds with unpaired electrons. In ESR, a sample is placed in a static magnetic field and irradiated with microwaves. This causes transitions between the electron spin energy levels. The absorption of microwave energy is detected to obtain an ESR spectrum. ESR spectra provide information about electron environments through parameters like g-values and hyperfine splitting patterns. ESR finds applications in studying transition metal complexes and unstable free radicals.
The document discusses different types and causes of anemia. It classifies anemia into etiologic categories including impaired red blood cell production, excessive destruction of RBCs, and blood loss. It further describes morphologic classifications such as macrocytic, microcytic hypochromic, and normocytic normochromic anemia. Specific causes are provided for each category including deficiencies, diseases, and genetic disorders. Hemolytic anemia is discussed in more detail including hereditary and acquired causes. Laboratory findings associated with different types of anemia are also summarized.
The document classifies anaemia into three main categories: blood loss anaemia, impaired red blood cell production, and excessive red blood cell destruction (haemolytic anaemia). Blood loss anaemia includes overt blood loss from injuries or procedures and occult bleeding from the GI or GU tract. Impaired production is due to nutrient deficiencies like iron, B12, and folate or conditions that suppress red blood cell formation. Excessive destruction includes hereditary defects affecting red blood cell membranes or haemoglobin as well as acquired immune or non-immune causes.
The erythrocyte sedimentation rate (ESR) is a non-specific screening test used to indicate inflammation. There are two methods to determine ESR - Westergren and Wintrobe, with Westergren being most widely used. The ESR test measures how far red blood cells fall in a vertical tube over one hour, and an increased rate can indicate conditions involving inflammation like kidney disease, pregnancy, rheumatoid arthritis, and infections. Precise procedure and standardization of factors like anticoagulant used and tube filling are required to obtain an accurate ESR result.
El documento describe la anemia, específicamente la anemia ferropénica y la anemia asociada a enfermedades crónicas. La anemia ferropénica es causada por deficiencia de hierro y es la forma más común de anemia. La anemia asociada a enfermedades crónicas ocurre comúnmente en personas con enfermedades como cáncer e infecciones y causa una anemia leve. El documento también cubre los síntomas, exámenes de laboratorio y tratamientos para estos tipos de anemia.
This document discusses various hemolytic diseases of the newborn. It describes the causes of hemolytic diseases including Rh incompatibility, autoimmune hemolytic anemia, hereditary spherocytosis, sickle cell disease, G6PD deficiency, and thalassemia. It provides details on the presentation, laboratory findings, diagnosis, and management of each condition. The most common cause of maternal isoimmunization is Rh incompatibility. Prevention involves administering anti-Rh D IgG to Rh negative mothers. Hemolytic diseases can cause anemia, jaundice, hepatosplenomegaly, and in severe cases, erythroblastosis fetalis.
This document provides an overview of pancytopenia, including its definition, etiology, clinical presentation, diagnostic workup, and treatment approach. Pancytopenia is defined as a low hemoglobin, white blood cell count, and platelet count. It can be caused by primary bone marrow diseases or secondary to other conditions that impair bone marrow function. The diagnostic workup involves blood tests, peripheral smear examination, bone marrow aspiration and biopsy for cytogenetics and immunophenotyping to identify the underlying cause. Specific tests help diagnose conditions like Fanconi anemia, lymphoproloferative disorders, and paroxysmal nocturnal hemoglobinuria. Treatment is directed at managing the specific disease identified as the cause
Anaemia is defined as a low haemoglobin level. It can be classified based on the mechanism (decreased red blood cell production or increased red blood cell loss) and mean corpuscular volume (MCV). Common symptoms include fatigue, dyspnea, and palpitations. Signs include pallor, jaundice, and heart murmurs. History should focus on iron loss, diet, medications, and family history. Investigations include full blood count, reticulocyte count, blood film, iron studies, folate, B12, and bone marrow biopsy if needed. The most common cause is iron deficiency due to blood loss. Treatment depends on the underlying cause.
Hematologic markers such as hemoglobin (Hb), hematocrit (Ht), mean corpuscular volume (MCV), and mean corpuscular hemoglobin concentration (MCHC) provide information about red blood cell (RBC) counts, size, and hemoglobin levels. Iron deficiency anemia results in microcytic, hypochromic RBCs and low levels of serum ferritin, iron, and transferrin saturation due to insufficient iron intake or absorption to support normal hemoglobin synthesis. Clinical presentation includes pallor, fatigue, and cardiovascular symptoms. Laboratory evaluation reveals microcytic RBCs on peripheral smear along with low Hb, Ht, MCV, MCH, and iron stores.
Hemolytic anemias are a group of disorders characterized by the premature destruction of red blood cells, either extravascularly by macrophages or intravascularly through complement activation or mechanical destruction. This results in increased amounts of hemoglobin being released into the circulation. Physical exam may reveal pallor, jaundice, splenomegaly, dark or red-brown urine, fever, or disease-specific symptoms. Laboratory findings include increased reticulocytes, low MCV, elevated bilirubin, low haptoglobin, plasma hemoglobin, or urinary hemoglobin. Hemolytic anemias can be classified based on abnormalities of the red blood cell interior, membrane, or extrinsic factors.
This document summarizes a presentation on congenital and acquired hemolytic anemias. It begins with general features and classifications of hemolytic anemias, including membranopathies, cation permeability defects, unstable hemoglobins, enzymopathies, methemoglobinemia, antibody-mediated, and microangiopathic anemias. It then discusses specific conditions in more detail, covering hereditary spherocytosis, elliptocytosis, pyropoikilocytosis, stomatocytosis syndromes, and their associated laboratory findings and treatments. The document provides an overview of red blood cell membrane disorders and cation permeability defects.
This document discusses blood formation and types of anemia. It explains that blood is composed of red cells, white cells, platelets, and plasma. Blood formation begins in the yolk sac in the 2nd week and later occurs chiefly in the liver and spleen, then the bone marrow. The bone marrow contains stem cells that can differentiate into mature blood cells. Various growth factors are involved in blood formation. The document also classifies and describes different types of anemia, including iron deficiency anemia, and lists causes and treatment for anemia.
This 20-year old male presented with a history of delayed growth, puberty, fever, severe joint pain and abdominal pain. Examination found pallor, icterus and tenderness. Labs showed anemia, elevated bilirubin and liver enzymes. Peripheral smear showed normocytic normochromic RBCs with some sickle cells. USG found gallstones and spleen not visualized. Hb electrophoresis showed HbS, consistent with sickle cell anemia.
This document provides information on the diagnosis of anemia. It defines anemia and outlines the grading and classification systems. It discusses the prevalence of anemia globally and in India. The clinical presentation and diagnostic workup are described. Guidelines are provided on evaluating different types of anemia based on red blood cell indices, including iron deficiency anemia, thalassemia, megaloblastic anemia, aplastic anemia, anemia of chronic disease, and hemolytic anemias. Diagnostic testing for specific conditions like sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency are also reviewed. The document emphasizes the importance of anemia as a public health problem and highlights approaches to differentiate between causes of anemia.
This document discusses the evaluation, causes, and treatment of various types of anemias. It covers topics such as the complications of anemia, genetic and acquired etiologies, nutritional deficiencies, physical causes, infections, neoplasms, and demographic factors. Evaluation involves medical history, physical exam, blood tests including complete blood count and smear, and imaging. Treatment depends on the underlying cause but may include blood transfusions, iron supplementation, bone marrow transplantation, splenectomy, and management of underlying conditions.
This document provides an overview of thalassemia including:
- A case study describing a patient presenting with symptoms of thalassemia
- Definitions and history of thalassemia
- Types of thalassemia including beta thalassemia major/intermedia/minor and alpha thalassemia
- Clinical features, complications, investigations and management of thalassemia
- Details on pathophysiology, inheritance, epidemiology and diagnosis of different thalassemia types
This document discusses an approach to diagnosing hemolytic anemia. The first step is to check the reticulocyte count to determine if the anemia is due to decreased red blood cell production or increased destruction. If the reticulocyte count is increased, a direct Coombs test is done. The peripheral blood smear is also examined to confirm or support the diagnosis. Based on Coombs test results, the cause of hemolysis can be intrinsic or extrinsic to the red blood cells. Additional tests are then used to determine the specific etiology or cause of hemolytic anemia.
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asadDr. Habibur Rahim
Dr. Habibur Rahman Bhuiyan and other doctors presented a seminar on thalassemia. They discussed a case of an 8-year-old boy with hereditary hemolytic anemia and symptoms of not growing well, pallor, and abdominal distension. The seminar covered the history, epidemiology, genetics, clinical presentations, complications, investigations, and management of different types of thalassemia including beta thalassemia major, beta thalassemia intermedia, HbE beta thalassemia, and alpha thalassemia. Investigations discussed included complete blood count, peripheral blood film, hemoglobin electrophoresis, and radiological imaging.
Halima, an 11-year-old girl with consanguineous parents, presented with not growing well, gradual pallor, and abdominal distension for 7 years. On examination, she was severely pale with facial dysmorphism and hepatosplenomegaly. Her history included repeated blood transfusions. She was diagnosed with hereditary hemolytic anemia. The seminar discussed thalassemia, including the types of thalassemia, clinical features, investigations, complications, and management with a focus on blood transfusions and chelation therapy.
This document provides an overview of the diagnostic approach to hemolytic anemia. It begins by classifying hemolytic anemias as either hereditary or acquired. For hereditary causes, it discusses various intracorpuscular and membrane defects that can cause hemolytic anemia such as hemoglobinopathies, enzymopathies, and membrane cytoskeletal defects. It then examines four case studies presenting with hemolytic anemia and provides differential diagnoses and investigations to arrive at the correct diagnosis for each case, which includes thalassemia major, sickle cell anemia, G6PD deficiency, and hereditary spherocytosis. The document emphasizes laboratory findings, peripheral blood smears, and diagnostic tests to differentiate between possible etiologies
This document provides an overview of hemolytic anemia, including its causes, clinical features, diagnostic testing, and peripheral smear findings. It discusses cellular defects like membrane defects, enzyme defects, and hemoglobin abnormalities that can cause hemolytic anemia. It also discusses extracellular causes such as immune hemolytic anemias, fragmentation hemolysis, and plasma factors. Diagnostic tests like LDH, bilirubin, haptoglobin, urine tests, and blood smears are described. Peripheral smear findings for different types of hemolytic anemias like spherocytes, elliptocytes, schistocytes, and dacrocytes are provided. Treatment options including blood transfusion, steroids, immunos
This document provides an overview of sickle cell disease, including:
- It is a genetic blood disorder caused by a mutation resulting in abnormal rigid red blood cells.
- Clinical features include anemia, pain crises, infections, stroke risk and organ damage over time.
- Diagnosis involves blood tests and genetic screening.
- Management focuses on hydration, pain control, antibiotics for infection, blood transfusions for crises, and lifelong folic acid supplementation.
This document contains an agenda and summary for a noon conference on bone marrow failure. The agenda includes discussing the pathogenesis, basic workup, additional tests that were done for a patient, and taking questions. The pathogenesis section outlines different causes of bone marrow failure including congenital issues, acquired issues, bone marrow infiltration/replacement, destruction/sequestration/redistribution, consumption, and ineffective hematopoiesis. The basic workup section lists various blood tests that should be considered. Additional tests that were done for their patient are also listed.
This document provides an overview of hemolytic anemia, including definitions, pathogenesis, classification, clinical features, laboratory findings, and approaches. Hemolytic anemia is characterized by increased red blood cell destruction. It can be hereditary or acquired. Specific hereditary forms discussed include hereditary spherocytosis, elliptocytosis, and pyropoikilocytosis, which are caused by red blood cell membrane defects. Clinical features may include pallor, jaundice, splenomegaly, and gallstones. Laboratory findings aid in diagnosis and include peripheral smear showing abnormal red blood cells, reticulocytosis, and elevated bilirubin. The document also discusses hemolytic anemia evaluation and differential diagnoses.
This document provides an overview of the management of hypertensive disorders in pregnancy. It discusses the differences between gestational hypertension and chronic hypertension, how to assess proteinuria, prevention strategies, recommendations for various stages of mild to severe hypertension during pregnancy and postpartum, which antihypertensive medications to use and avoid, risk factors for preeclampsia, and conclusions about early diagnosis and treatment improving outcomes for both mother and baby. The conclusions recommend labetolol and methyldopa as first-line drugs, watching high risk women closely for preeclampsia, using urine protein to creatinine ratio for proteinuria screening, and aspirin as the only proven primary prevention method.
This document discusses the clinical relevance and prognostic significance of morning surge in blood pressure in patients with hypertension. It begins by defining different dipping patterns seen in ambulatory blood pressure monitoring, including dippers, extreme dippers, non-dippers, and risers. It then reviews evidence from several long-term studies showing that non-dipping and morning surge are associated with increased cardiovascular risk. The document discusses factors that influence dipping status and examines differences in effects of antihypertensive drug classes on daytime and nighttime blood pressure. It emphasizes the importance of controlling morning blood pressure surge and maintaining normal circadian rhythm patterns.
Diabetes management in Ramadan presents medical challenges as many Muslim patients with diabetes insist on fasting during Ramadan. The document discusses:
1) Major risks of fasting including hypoglycemia, hyperglycemia, diabetic ketoacidosis, and dehydration.
2) Categories of diabetes risk for fasting - very high, high, moderate, low.
3) Recommendations for diabetes management during Ramadan including adjusting medications, monitoring blood sugar, nutrition, exercise and breaking the fast if complications occur.
4) Studies showing education programs can help improve diabetes control and reduce risks when fasting during Ramadan.
The document provides an update on new anti-malarial drugs. It discusses currently used anti-malarials and their limitations, demonstrating the need for new drugs. Several new drug targets and drugs in clinical trials are presented. Drugs in Phase III include arterolane combined with piperaquine, dihydroartemisinin combined with piperaquine, and artesunate combined with pyronaridine. Drugs in early phases of development show promise but require further testing for safety, efficacy, and advantages over existing therapies. Overall the document outlines progress and continued research efforts to develop improved anti-malarial treatment options.
The document discusses thyroid disease and hypothyroidism, outlining the process of hormone production in the thyroid gland, symptoms and effects of hypothyroidism on organ systems, diagnosis using thyroid function tests, and treatment involving normalization of TSH levels with levothyroxine replacement therapy.
This document summarizes the posterior circulation of the brain. It describes how the vertebral arteries join to form the basilar artery in the brainstem. The basilar artery then divides into the two posterior cerebral arteries. Key branches include the posterior inferior cerebellar artery and superior cerebellar artery. The posterior cerebral arteries supply blood to the occipital and temporal lobes. The vertebrobasilar system provides blood to the brainstem, cerebellum, and posterior portions of the telencephalon.
This document summarizes the functional anatomy of the cerebral hemispheres. It describes the six layers of the cerebral cortex and areas related to somatosensory, motor, visual, auditory, and olfactory functions. It discusses association areas including the parietooccipitotemporal area, prefrontal cortex, Wernicke's area, and angular gyrus. It also briefly mentions control of eye movements, face recognition, speech processing, and functions of the non-dominant hemisphere.
The document discusses the anterior cerebral circulation, including the internal carotid artery, anterior cerebral artery, and middle cerebral artery. It describes the typical vascular territories and clinical deficits that can result from occlusions or infarctions in different segments of these arteries. Key points include that unilateral middle cerebral artery occlusion can cause contralateral hemiplegia and homonymous hemianopia, while bilateral anterior cerebral artery occlusion can lead to paraplegia and urinary incontinence.
This document provides an overview of the posterior cerebral circulation and blood supply of the spinal cord. It discusses the anatomy and branches of the posterior cerebral artery, vertebral arteries, basilar artery, and artery of Adamkiewicz. Syndromes related to occlusions in these vessels are outlined, including P1/P2 PCA syndromes, lateral medullary syndrome, basilar artery syndromes, and anterior spinal artery syndrome. The circle of Willis and variations in posterior circulation anatomy are also briefly mentioned.
The document discusses various spinal cord syndromes classified as either complete or incomplete cord syndromes. It provides details on complete cord transection which results in paralysis, loss of sensation, and autonomic dysfunction below the level of injury. Brown-Sequard syndrome and central cord syndrome are discussed as examples of incomplete cord syndromes characterized by mixed upper and lower motor neuron findings on one or both sides of the body. The document also covers syndromes involving specific regions of the spinal cord including conus medullaris, cauda equina, and anterior spinal artery syndromes.
Systemic Lupus Erythematosus (SLE) is an inflammatory autoimmune disease characterized by excessive autoantibody production leading to tissue damage. It has a wide variety of clinical manifestations that can affect many different organ systems. Some key points:
- SLE predominantly affects women of childbearing age and has a strong genetic component. Certain genetic and environmental factors can increase risk.
- Clinical features include skin rashes, arthritis, kidney involvement ranging from mild proteinuria to severe nephritis, neurological/psychiatric symptoms, hematological abnormalities and involvement of other organs.
- Diagnosis is based on identifying a combination of clinical and laboratory criteria including high titers of antinu
This document summarizes key points about hypoglycemia and diabetic emergencies. It defines hypoglycemia and describes glucose homeostasis and the body's response to low blood sugar levels. The clinical features and mechanisms of hypoglycemia are outlined. Hypoglycemia is classified as either postabsorptive or postprandial. Postabsorptive hypoglycemia implies an underlying disease that requires diagnosis and treatment. Hypoglycemia is a major problem for patients with diabetes and predisposes them to recurrent low blood sugar episodes through hypoglycemia-associated autonomic failure. Conventional risk factors are based on relative or absolute insulin excess compromising the body's natural defenses against dropping glucose levels.
The document discusses the differences between diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), noting that DKA involves hyperglycemia, ketosis and acidosis while HHS involves severe hyperglycemia and hyperosmolarity without acidosis. It provides details on the pathophysiology, clinical presentation, diagnostic evaluation and treatment approaches for DKA and HHS, emphasizing the goals of treatment as improving circulation, gradually reducing glucose and correcting electrolyte imbalances.
Mrs. Vijaya, a 31-year-old housewife, presented with a 2-month history of fever, 45-day history of malar rash and headaches. Her examination found malar rash, macular erythema on palms and back, and lab tests showed positive ANA and anti-dsDNA antibodies. She met 4 of the 11 criteria for systemic lupus erythematosus (SLE). She was diagnosed with SLE and treated with methylprednisolone, azathioprine, and prednisolone, with improvement in her symptoms though she developed alopecia and GI symptoms.
Beta blockers such as atenolol have been shown to have a relatively weak effect in reducing stroke compared to other antihypertensive classes such as calcium channel blockers, ACE inhibitors, and thiazide diuretics. Evidence from Cochrane reviews shows that beta blockers do not reduce the risk of coronary heart disease compared to placebo or no treatment, and they may increase the risk of all-cause mortality and total cardiovascular disease compared to calcium channel blockers. While beta blockers lower the risk of total cardiovascular disease compared to placebo primarily by reducing stroke risk, their effect on other outcomes is not better than other classes of antihypertensive medications.
The document describes the case of a 26-year-old female who presented with shortness of breath and was initially diagnosed with anxiety but later diagnosed with acute pulmonary thromboembolism. It then reviews the epidemiology, pathophysiology, risk factors, clinical features, diagnosis, natural history, and management of acute pulmonary thromboembolism, with a focus on topics relevant to critically ill patients.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
1. In the name of God, Most Gracious, Most Merciful
2. EVALUATION OF A CASE OF ANAEMIA
- Dr. Mohammed Sadiq Azam
PG M:1 (Dr. Siraj’s Unit)
DCMS @ PEH
3. CASE HISTORIES:
• 22/F presented with complaints of shortness of breath (NYHA GR IV),
orthopnoea+, chest discomfort and palpitations on exertion which gradually
increased over the last 6 months to attain present severity. H/s/o Pica+, H/o
passing worms in stools+. No h/o rash, photosensitivity or seizures. O/E: Pallor+,
BPPE+, JVP ↑, s3 gallop+, b/l basal creps (fine)+, no organomegaly, no FF.
• 45/F presented with c/o shortness of breath (NYHA GR II-III), no orthopnoea, no
PND. Past h/o jaundice+. H/o blood transfusion in past +. O/E: Pallor++, Icterus++
+, Hepatomegaly~2 cm below C/m, Splenomegaly~15cm, no FF.
• 75/F presented with c/o fatigability and lethargy over last 8 month, initially mild
now increased in intensity. H/o sob on exertion (NYHA GR I-II). No H/o
orthopnoea/PND. No H/o chest discomfort. Not a known diabetic. H/s/o malena+.
H/o loss of appetitie, loss of weight+ over last 5 months. O/E: Pallor++, anicteric
no PE, CVS/RS – NAD, P/A- NAD.
4. EVALUATION – HISTORY:
• Age/Sex
• Rate of onset – Rapid/Slow
• Blood loss – Haematemesis / malena / bleeding piles / menorrhagia /
metorrhagia / epistaxis / hematuria / haemoptysis
• Abdomen – Appetitie / weight loss / dysphagia / regurgitation / dyspepsia / abd
pain / diarrhoea / constipation / jaundice / soreness of tongue / previous abd
surgeries
• Reproductive – Menstrual history in detail / number & interval between
pregnancies / miscarriages
• Urinary system – Nocturnal polyuria
• CNS – Parasthesiae / difficulty in walking
5. EVALUATION – HISTORY:
• Bleeding tendency – Easy bruising / prolonged bleeding after trivial injuries /
bleeding from more than one site
• Skeletal system – Bone pain / Arthritis / Arthralgia
• Temperature – Fever / Night sweats
• Drug ingestion – Previuos / current
• Occupation – Metal dusts / solvent fumes / lead
• Diet
• Social history – Alcoholism
• Past H/o – Previous anaemia: diag & Rx, response to Rx
• Family H/o – Anaemia / recurrent jaundice / IUD & childhood deaths
9. Is anemia associated with other haematological abnormalities?
Yes No
BM Examination Is there an appropriate reticulocyte response to anaemia?
Leukemias
Aplastic anaemias Yes No
MDS / MF
Myelophthisis RBC Indices
Megaloblastic anaemia
Evidence of haemolysis? MCV >100 MCV 80-100 MCV <80
Yes No Evaluate:
Normocytic anemia
Evaluate cause Evaluate: Evaluate: Evaluate:
of haemolysis haemorrhagic causes Macrocytic anemia Microcytic anemia
(Ref: Bertil Glader: Anaemia: General Considerations, Wintrobe’s Clinical Haematology 11/e, 2004: 951-978)
10. RETICULOCYTOSIS: A WORD
• Retic count = % reticulocytes in RBC population
• Retic count corrected for anaemia = % retculocytes x pt Hb/15 or pt Hct/45
• BUT, Retics released under intense EPO stimulation remain in circulation for approx 2x the usual 1 day
survival of non stress retics, so:
• Corrected Retic index = Retic count corrected for anaemia x 0.5
• < 2.5 = inadequate response – hypoprolifertive / maturation disorder (marrow prod impaired)
• ≥ 2.5 = adequate response – haemolytic / haemorrahgic
• Absolute retic count = %retics x RBC count/l3
• Low retic count + active marrow erythropoiesis = ineffective erythropoiesis
• IDA
• Sideroblastic anaemia
• Thalassemias
• (Also associated with ↑ LDH)
11. Macrocytic anaemia
Does the P/S reveal hypersegmented neutrophils / macroovalocytes?
Yes No
Nonmegaloblastic anaemia
Megaloblastic anaemia – BM to confirm
Test for B12/Folate levels
↑ Reticulocytosis
B12 def No def Folate def Haemolytic N/↓
Schilling’s test: Inherited disorders of DNA syn Poor diet Consider:
Corrects with IF Drugs tht interfere with DNA syn Drug induced malabs - Alcohol
Jejuneal resection - Hypothyroidism
Tropical sprue - Liver disease
Yes No Ileal disease
Previous ileal Sx
Gluten sensitivity
Small bowel bac overgrowth ↑ Needs If NO: BM exam
Pernicious anaemia: Fish tapeworm - Pregnancy
Gastric resection Drug induced malabsorption - Chronic hemolysis - MDS
- Red cell aplasia
- Acq siderobl anaemia
- Herid dyserythropoietic
anaemia (I& III)
(Ref: Bertil Glader: Anaemia: General Considerations, Wintrobe’s Clinical Haematology 11/e, 2004: 951-978)
12. Microcytic anaemia Appropriate age: Rule out malignancy
Reticulocytes
Low / N Increased
Iron Profile P/S: Abnorm morphology
Labs for ↑ RBC destruc
↓ Fe ↓ Fe N. Fe ↑ Fe Hb studies
↑ TIBC N/↓ TIBC N. TIBC N. TIBC
↓ Ferritin N/↑ Ferritin N. Ferritin ↑ Ferritin - Homozygous β thal
- Haemolytic elliptocyt
- Herid pyropoikilocytosis
Iron deficiency
↑ ESR, CRP+ Hb electrophoresis
or other studies BM examination with Fe stains
s/o underlying
Inflammatory disorder - α Thal trait
- β Thal trait
- Hb E syn
AOCD - Hb C disorder Sideroblastic anaemia
(Ref: Bertil Glader: Anaemia: General Considerations, Wintrobe’s Clinical Haematology 11/e, 2004: 951-978)
13. Normocytic anaemia
Reticulocytes
↑ RBC prod N./↓ RBC prod
H/o jaundice, splenomegaly - S. Chemistries to screen S.Fe
Presence of P/S abnormalities for renal, hepatic, endocrine
↑ Bilirubin / LDH disease
- Consider EPO levels, thyroid studies
Yes Haemolysis
Low
Positive Negative N. / High
No Haemolytic anaemia AOCD
BM aspirate & Bx Early IDA
- Anaemia of renal disease
- Anaemia of liver disease - Infiltrative disorder
- Anaemia due to endocrine failure (Leuk, myeloma, MF, Mets)
- Red cell aplasia
- MDS
- Dyserythropoietic anaemia (Type II)
(Ref: Bertil Glader: Anaemia: General Considerations, Wintrobe’s Clinical Haematology 11/e, 2004: 951-978)
14. HAEMORRHAGIC ANAEMIA:
• Retic index ≥ 2.5. Polychromatophilic macrocytes ++ in P/S
• Marrow examination is rarely required if retic index is increased appropriately.
• RBC indices are typically normocytic or slightly macrocytic (reflects ↑ retics)
Blood loss
Acute Missed
Subacute Chronic
No reticulocytosis Presents ///ar to IDA
Observe for 2-3 weeks
Signs of recovery
Modest reticulocytosis - Hb ↑
- Retic count ↓
15. HAEMORRHAGIC ANAEMIA:
Volume of Blood Symptoms
blood loss (ml) volume (%)
500-1000 10-20 Few if any symptoms
1000-1500 20-30 Asymptomatic while at rest in a recumbent position; light headedness
and hypotension when upright; tachycardia
1500-2000 30-40 Symptoms present when recumbent; thirst, SOB, clouding or LOC;
BP, CO, venous pressure decrease, pulse usually rapid; extremities
become cold, clammy & pale
2000-2500 40-50 Lactic acidosis, shock; irreversible shock, death
16. HAEMOLYTIC ANAEMIA:
• Least common form of anaemia
• High retic count: Reflects the ability of the erythroid marrow to compensate
for haemolysis, and, in the case of extravascular haemolysis, the efficient
recycling of iron from the destroyed RBC to support RBC production.
• Intravascular haemolysis – PNH – loss of Fe – limits marrow response
• Hence, the level of marrow response depends on:
• The severity of anaemia
• The nature of the underlying disease process
• Hemoglobinopathies – mixed picture. (Retic count is ↑ but ↓ with respect to
degree of marrow erythroid hyperplasia).
17. HAEMOLYTIC ANAEMIA:
• Presentation varies:
• Acute self limiting illness (autoimmune/EM pathway/GR defects)
• Chronic process (Hb defects/ RBC defects) with a typical history
• HS: chronic course – present with complications such as bilirubin
gallstones or splenomegaly and not anaemia per se.
• Chronic haemolysis also prone to aplastic anaemia if infections occur.
18. HAEMOLYTIC ANAEMIA: INTRAVASCULAR LYSIS
• PNH
• Erythrocyte fragmentation disorders
• Transfusion reactions resulting from ABO incompatability
• Paroxysmal cold haemoglobinuria
• AIHA (occasionally)
• Infections:
• Blackwater fever in falciparum malaria
• Clostridial sps
• Chemical mediated:
• Arsine poisoning
• Snake & Spider venoms
• Acute drug reactions with G6PD def
• I.V. admin of distilled water
• Thermal injury
19. HAEMOLYTIC ANAEMIA: LABS
• Morphological abnormalities: Spherocytes, Elliptocytes, Stomatocytes,
Acanthocytes, Echinocytes, Sickle cells, Target cells, Schistocytes
• Direct Antiglobulin test (Coomb’s test): +ve in IHA (2-5% false neg)
• Osmotic fragility test : HS (Osmotic gradient ektacytometry is more sensitve
& specific, but not widely available)
• Tests for Heinz bodies (supravital staining): G6PD def, unstable Hb
disease, thalassemias, chemicals. (Not seen when spleen is intact)
20. HAEMOLYTIC ANAEMIA: D/D
• Asso with anaemia & retculocytosis:
• Hemorrhage
• Recovery from iron, folate or vitamin B12 deficiency
• Recovery from marrow failure
• Asso with jaundice & anaemia:
• Ineffective erythropoiesis (intramedullary erythropoiesis)
• Bleeding into a body cavity or tissue
• Asso with jaundice without anaemia
• Defective bilirubin conjugation
• Crigler-Najjar syndrome
• Gilbert syndrome
• Marrow invasion
• Myoglobinuria
21. CONCLUSION:
• Any case of anaemia requires a detailed work up starting with history.
• Stepwise approach is the golden rule.
• IDA in elderly – avoid being ‘Penny wise, Pound foolish’
• In tropical countries, tropical malabsorption syndromes are more rampant than
we realize – LOOK OUT, it may be missed unless you look for it.
• Better not to start any IFA or B12 supplements until we diagnose the cause of
anaemia.
• Bone marrow is not the answer to every anaemia – AVOID indiscriminate use.
• No cost is greater than the patient’s life. Investigate what’s mandatory.
• Delayed diagnosis is better than a wrong diagnosis – DO NOT hurry to treat.